For example, increased CD4NC cell-specific DDTL expression was found to be associated with higher CAD risk, whereas increased MonoC-specific LRRFIP2 expression was found to be associated with higher PAD risk. This evidence concerns the gene LRRFIP2 and peripheral arterial disease.